We are live on ! Find out more
Parallel Advisors

Parallel Advisors Portfolio holdings

AUM $6.56B Turnover 11.49%
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+11.59%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$3.37B
AUM Growth
+$369M
Cap. Flow
+$44.9M
Cap. Flow %
1.33%
Top 10 Hldgs %
35.85%
Holding
3,551
New
186
Increased
1,137
Reduced
1,414
Closed
232
Avg Time Held Equity + Options
4 years
Top 10 Avg Time Held Equity + Options
2.4 years
Top 20 Avg Time Held Equity + Options
2.7 years
Avg Time Held Equity only
4 years
Top 10 Avg Time Held Equity only
2.4 years
Top 20 Avg Time Held Equity only
2.7 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 48.92%
2 Technology 14.72%
3 Healthcare 9.12%
4 Financials 6.99%
5 Consumer Discretionary 4.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
KALA icon
3276
KALA BIO
KALA
$3.72M
– –
0
– –
2021 Q1
11 quarters
CENN icon
3277
Cenntro
CENN
$7.74M
– –
0
– –
2021 Q2
10 quarters
VIRX icon
3278
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$5 ﹤0.01%
8
– –
2018 Q4
20 quarters
VRPX icon
3279
DELISTED
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
– –
0
– –
2023 Q4
0 quarters
BTBT icon
3280
Bit Digital
BTBT
$389M
$4 ﹤0.01%
+1
New +$3
2023 Q1
3 quarters
DCTH icon
3281
Delcath Systems
DCTH
$514M
$4 ﹤0.01%
1
– –
2020 Q2
14 quarters
VMEO icon
3282
DELISTED
Vimeo
VMEO
$4 ﹤0.01%
1
-1,109
-100% -$3.96K
2022 Q2
6 quarters
IMUX icon
3283
Immunic
IMUX
$96.9M
– –
0
– –
2018 Q2
22 quarters
TVRD icon
3284
Tvardi Therapeutics
TVRD
$14.3M
– –
0
– –
2023 Q4
0 quarters
CCO icon
3285
Clear Channel Outdoor Holdings
CCO
$1.23B
$2 ﹤0.01%
1
– –
2023 Q2
2 quarters
GWAV icon
3286
Greenwave Technology Solutions
GWAV
$2.03M
– –
0
– –
2023 Q1
3 quarters
LGMK icon
3287
DELISTED
LogicMark
LGMK
– –
0
– –
2023 Q4
0 quarters
TNXP icon
3288
Tonix Pharmaceuticals
TNXP
$110M
– –
0
– –
2023 Q4
0 quarters
WINT icon
3289
DELISTED
Windtree Therapeutics
WINT
– –
0
– –
2020 Q2
14 quarters
XXII
3290
22nd Century Group
XXII
$448K
– –
0
– –
2018 Q2
22 quarters
YYAI icon
3291
AiRWA Inc
YYAI
$3.45M
– –
0
– –
2022 Q3
5 quarters
FFAI
3292
Faraday Future Intelligent Electric
FFAI
$5.07M
– –
0
– –
2021 Q3
9 quarters
THMO icon
3293
DELISTED
ThermoGenesis Holdings, Inc. Common Stock
THMO
$1 ﹤0.01%
1
– –
2019 Q2
18 quarters
ABCB icon
3294
Ameris Bancorp
ABCB
$5.35B
– –
-16
Closed -$614 –
ABG icon
3295
Asbury Automotive
ABG
$3.05B
– –
-30
Closed -$6.9K –
ACEL icon
3296
Accel Entertainment
ACEL
$898M
– –
-654
Closed -$7.16K –
AGIO icon
3297
Agios Pharmaceuticals
AGIO
$1.93B
– –
-23
Closed -$569 –
ALTG icon
3298
Alta Equipment Group
ALTG
$197M
– –
-157
Closed -$1.89K –
ANIK icon
3299
Anika Therapeutics
ANIK
$277M
– –
-14
Closed -$261 –
ANGO icon
3300
AngioDynamics
ANGO
$487M
– –
-72
Closed -$526 –

Similar funds

Parallel Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, Parallel Advisors held 3,551 positions worth $3.37B, up 12% from $3B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Parallel Advisors's Q4 2023 filing shows 186 new, 1,137 increased, 1,414 reduced and 232 closed positions. Its largest new stake was PIMCO Multi Sector Bond Active ETF: 62,879 shares worth $1.61M. The largest sale was Schwab US Dividend Equity ETF, an estimated $69.6M.

By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, up from 47% a quarter earlier, followed by Technology and Healthcare.

  • Parallel Advisors's largest Q4 2023 buy was PIMCO Multi Sector Bond Active ETF: 62,879 shares worth $1.61M.
  • Parallel Advisors added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $174M increase.
  • Parallel Advisors's biggest Q4 2023 reduction was Schwab US Dividend Equity ETF, cutting an estimated $69.6M.
  • Parallel Advisors fully exited Activision Blizzard in Q4 2023, selling an estimated $591K.
  • Parallel Advisors's ten largest holdings make up 36% of its $3.37B portfolio in Q4 2023.
  • Parallel Advisors opened 186 new positions and closed 232 in Q4 2023.
  • Parallel Advisors's portfolio value rose 12% quarter-over-quarter to $3.37B.

Based on Parallel Advisors's 13F filing for Q4 2023, filed 12 Feb 2024.